Samsung Bioepis

Developer of biosimilar drugs for the treatment of multiple diseases

placeIncheon, Incheon, South Korea calendar_todayFounded 2012 groups548 employees language samsungbioepis.com

Registered entities

Innovation

60 patent families (20 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 1,060 times.

YearFilings
20169
20173
201811
201911
202015
202113
202214
20237
202412
202514
20268

Investor mix

2 investors on record.

Investor typeCountShare
Other / undisclosed2100%
Coming soon